|
1
|
SGO Clinical Practice Endometrial Cancer
Working Group; Burke WM, Orr J, Leitao M, Salom E, Gehrig P,
Olawaiye AB, Brewer M, Boruta D, Villella J, et al: Endometrial
cancer: A review and current management strategies: Part I. Gynecol
Oncol. 134:385–392. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bokhman JV: Two pathogenetic types of
endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hecht JL and Mutter GL: Molecular and
pathologic aspects of endometrial carcinogenesis. J Clin Oncol.
24:4783–4791. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Henderson BE, Casagrande JT, Pike MC, Mack
T, Rosario I and Duke A: The epidemiology of endometrial cancer in
young women. Br J Cancer. 47:749–756. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Koskas M, Uzan J, Luton D, Rouzier R and
Daraï E: Prognostic factors of oncologic and reproductive outcomes
in fertility-sparing management of endometrial atypical hyperplasia
and adenocarcinoma: Systematic review and meta-analysis. Fertil
Steril. 101:785–794. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Manson JE, Chlebowski RT, Stefanick ML,
Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson
CA, LaCroix AZ, et al: Menopausal hormone therapy and health
outcomes during the intervention and extended post-stopping phases
of the Women's Health Initiative randomized trials. JAMA.
310:1353–1368. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hollenberg SM, Sternglanz R, Cheng PF and
Weintraub H: Identification of a new family of tissue-specific
basic helix-loop-helix proteins with a two-hybrid system. Mol Cell
Biol. 15:3813–3822. 1995.PubMed/NCBI
|
|
8
|
Firulli AB: A HANDful of questions: The
molecular biology of the heart and neural crest derivatives
(HAND)-subclass of basic helix-loop-helix transcription factors.
Gene. 312:27–40. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dai YS, Cserjesi P, Markham BE and
Molkentin JD: The transcription factors GATA4 and dHAND physically
interact to synergistically activate cardiac gene expression
through a p300-dependent mechanism. J Biol Chem. 277:24390–24398.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamagishi H, Yamagishi C, Nakagawa O,
Harvey RP, Olson EN and Srivastava D: The combinatorial activities
of Nkx2.5 and dHAND are essential for cardiac ventricle formation.
Dev Biol. 239:190–203. 2001. View Article : Google Scholar
|
|
11
|
Rychlik JL, Gerbasi V and Lewis EJ: The
interaction between dHAND and Arix at the dopamine beta-hydroxylase
promoter region is independent of direct dHAND binding to DNA. J
Biol Chem. 278:49652–49660. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Morikawa Y, Dai YS, Hao J, Bonin C, Hwang
S and Cserjesi P: The basic helix-loop-helix factor Hand 2
regulates autonomic nervous system development. Dev Dyn.
234:613–621. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Firulli BA, Hadzic DB, McDaid JR and
Firulli AB: The basic helix-loop-helix transcription factors dHAND
and eHAND exhibit dimerization characteristics that suggest complex
regulation of function. J Biol Chem. 275:33567–33573. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dai YS and Cserjesi P: The basic
helix-loop-helix factor, HAND2, functions as a transcriptional
activator by binding to E-boxes as a heterodimer. J Biol Chem.
277:12604–12612. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Q, Kannan A, DeMayo FJ, Lydon JP, Cooke
PS, Yamagishi H, Srivastava D, Bagchi MK, Bagchi IC, et al: The
antiproliferative action of progesterone in uterine epithelium is
mediated by Hand2. Science. 331:912–916. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jones A, Teschendorff AE, Li Q, Hayward
JD, Kannan A, Mould T, West J, Zikan M, Cibula D, Fiegl H, et al:
Role of DNA methylation and epigenetic silencing of HAND2 in
endometrial cancer development. PLoS Med. 10:e10015512013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wada-Hiraike O, Yano T, Nei T, Matsumoto
Y, Nagasaka K, Takizawa S, Oishi H, Arimoto T, Nakagawa S, Yasugi
T, et al: The DNA mismatch repair gene hMSH2 is a potent
coactivator of oestrogen receptor alpha. Br J Cancer. 92:2286–2291.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koyama S, Wada-Hiraike O, Nakagawa S,
Tanikawa M, Hiraike H, Miyamoto Y, Sone K, Oda K, Fukuhara H,
Nakagawa K, et al: Repression of estrogen receptor beta function by
putative tumor suppressor DBC1. Biochem Biophys Res Commun.
392:357–362. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fu H, Wada-Hiraike O, Hirano M, Kawamura
Y, Sakurabashi A, Shirane A, Morita Y, Isono W, Oishi H, Koga K, et
al: SIRT3 positively regulates the expression of folliculogenesis-
and luteinization-related genes and progesterone secretion by
manipulating oxidative stress in human luteinized granulosa cells.
Endocrinology. 155:3079–3087. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hiraike H, Wada-Hiraike O, Nakagawa S,
Koyama S, Miyamoto Y, Sone K, Tanikawa M, Tsuruga T, Nagasaka K,
Matsumoto Y, et al: Identification of DBC1 as a transcriptional
repressor for BRCA1. Br J Cancer. 102:1061–1067. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cullinan-Bove K and Koos RD: Vascular
endothelial growth factor/vascular permeability factor expression
in the rat uterus: Rapid stimulation by estrogen correlates with
estrogen-induced increases in uterine capillary permeability and
growth. Endocrinology. 133:829–837. 1993.PubMed/NCBI
|
|
22
|
Bersten DC, Sullivan AE, Peet DJ and
Whitelaw ML: bHLH-PAS proteins in cancer. Nat Rev Cancer.
13:827–841. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
White TE and Gasiewicz TA: The human
estrogen receptor structural gene contains a DNA sequence that
binds activated mouse and human Ah receptors: A possible mechanism
of estrogen receptor regulation by
2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Biophys Res Commun.
193:956–962. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ohtake F, Baba A, Takada I, Okada M,
Iwasaki K, Miki H, Takahashi S, Kouzmenko A, Nohara K, Chiba T, et
al: Dioxin receptor is a ligand-dependent E3 ubiquitin ligase.
Nature. 446:562–566. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Swedenborg E and Pongratz I: AhR and ARNT
modulate ER signaling. Toxicology. 268:132–138. 2010. View Article : Google Scholar
|
|
26
|
Ohtake F, Takeyama K, Matsumoto T,
Kitagawa H, Yamamoto Y, Nohara K, Tohyama C, Krust A, Mimura J,
Chambon P, et al: Modulation of oestrogen receptor signalling by
association with the activated dioxin receptor. Nature.
423:545–550. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Welboren WJ, Sweep FC, Span PN and
Stunnenberg HG: Genomic actions of estrogen receptor alpha: What
are the targets and how are they regulated? Endocr Relat Cancer.
16:1073–1089. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou W and Slingerland JM: Links between
oestrogen receptor activation and proteolysis: Relevance to
hormone-regulated cancer therapy. Nat Rev Cancer. 14:26–38. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fan S, Wang J, Yuan R, Ma Y, Meng Q, Erdos
MR, Pestell RG, Yuan F, Auborn KJ, Goldberg ID, et al: BRCA1
inhibition of estrogen receptor signaling in transfected cells.
Science. 284:1354–1356. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dirkx E, Gladka MM, Philippen LE, Armand
AS, Kinet V, Leptidis S, El Azzouzi H, Salic K, Bourajjaj M, da
Silva GJ, et al: Nfat and miR-25 cooperate to reactivate the
transcription factor Hand2 in heart failure. Nat Cell Biol.
15:1282–1293. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yamagishi H, Garg V, Matsuoka R, Thomas T
and Srivastava D: A molecular pathway revealing a genetic basis for
human cardiac and craniofacial defects. Science. 283:1158–1161.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bondesson M, Hao R, Lin CY, Williams C and
Gustafsson JA: Estrogen receptor signaling during vertebrate
development. Biochim Biophys Acta. 1849:142–151. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Grady D, Rubin SM, Petitti DB, Fox CS,
Black D, Ettinger B, Ernster VL and Cummings SR: Hormone therapy to
prevent disease and prolong life in postmenopausal women. Ann
Intern Med. 117:1016–1037. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mueller MD, Vigne JL, Minchenko A, Lebovic
DI, Leitman DC and Taylor RN: Regulation of vascular endothelial
growth factor (VEGF) gene transcription by estrogen receptors alpha
and beta. Proc Natl Acad Sci USA. 97:10972–10977. 2000. View Article : Google Scholar : PubMed/NCBI
|
